Drug Type Monoclonal antibody |
Synonyms EB-07 |
Target |
Mechanism TLR4 antagonists(Toll like receptor 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Scleroderma, Systemic | Phase 2 | US | 30 Jan 2022 |